Arformoterol Oral Inhalation

Arformoterol Oral Inhalation is a topic covered in the Consumer DrugInfo.

To view the entire topic, please or purchase a subscription.

Explore these free sample topics:

-- The first section of this topic is shown below --

General

Pronunciation:
(ar'' for moe' ter ol)

Brand name:

  • Brovana®

Important Warning

In a large clinical study, more people who used an asthma medication similar to arformoterol experienced more severe episodes of asthma that needed to be treated in a hospital or caused death than patients who did not use the medication. Use of arformoterol inhalation may increase the risk of serious asthma problems or death in people who have asthma. Arformoterol has not been approved by the Food and Drug Administration (FDA) to treat asthma. There is not enough information to tell whether arformoterol increases the risk of death in people who have chronic obstructive pulmonary disease (COPD; a group of lung diseases, which includes chronic bronchitis and emphysema).

Your doctor or pharmacist will give you the manufacturer's patient information sheet (Medication Guide) when you begin treatment with arformoterol and each time you refill your prescription. Read the information carefully and ask your doctor or pharmacist if you have any questions. You can also visit the Food and Drug Administration (FDA) website (http://www.fda.gov/Drugs/DrugSafety/ucm085729.htm) or the manufacturer's website to obtain the Medication Guide.

Talk to your doctor about the risks of using arformoterol inhalation.

-- To view the remaining sections of this topic, please or purchase a subscription --

Citation

* When formatting your citation, note that all book, journal, and database titles should be italicized* Article titles in AMA citation format should be in sentence-case
TY - ELEC T1 - Arformoterol Oral Inhalation ID - 112277 PB - Consumer DrugInfo UR - http://familydrugguide.com/family/view/Consumer_DrugInfo/112277/all/Arformoterol_Oral_Inhalation ER -